These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31632008)

  • 1. Erratum: Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum].
    Int J Nanomedicine; 2019; 14():7919. PubMed ID: 31632008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum].
    Int J Nanomedicine; 2022; 17():5047-5048. PubMed ID: 36303805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum].
    Int J Nanomedicine; 2019; 14():8753-8754. PubMed ID: 31806969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis and Reduces Tumor Volume Along with Drug-Related Cardiotoxicity in Mice [Corrigendum].
    Int J Nanomedicine; 2021; 16():1001-1003. PubMed ID: 33603364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: CD-340 Functionalized Doxorubicin-Loaded Nanoparticle Induces Apoptosis And Reduces Tumor Volume Along With Drug-Related Cardiotoxicity In Mice [Corrigendum].
    Int J Nanomedicine; 2019; 14():9307. PubMed ID: 31819432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
    Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum].
    Int J Nanomedicine; 2021; 16():4191-4192. PubMed ID: 34168451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum].
    Int J Nanomedicine; 2021; 16():7859-7860. PubMed ID: 34880611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin [Corrigendum].
    Int J Nanomedicine; 2021; 16():8335-8336. PubMed ID: 34992369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Doxorubicin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles Coated with Chitosan/Alginate by Layer by Layer Technology for Antitumor Applications [Corrigendum].
    Int J Nanomedicine; 2021; 16():4187. PubMed ID: 34177263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum].
    Int J Nanomedicine; 2021; 16():7683-7684. PubMed ID: 34848954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum].
    Int J Nanomedicine; 2019; 14():6867. PubMed ID: 31509111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Inhibition of Proliferation and Migration of Tumor Cells Through Phenylboronic Acid-Functionalized Polyamidoamine-Mediated Delivery of a Therapeutic DNAzyme Dz13 [Corrigendum].
    Int J Nanomedicine; 2021; 16():8117-8119. PubMed ID: 34949920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: VCAM-1-Targeted Core/Shell Nanoparticles for Selective Adhesion and Delivery to Endothelial Cells with Lipopolysaccharide-Induced Inflammation under Shear Flow and Cellular Magnetic Resonance Imaging in vitro [Corrigendum].
    Int J Nanomedicine; 2022; 17():3401-3402. PubMed ID: 35942071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum].
    Int J Nanomedicine; 2021; 16():7283-7284. PubMed ID: 34737565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum].
    Int J Nanomedicine; 2020; 15():839. PubMed ID: 32103940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].
    Int J Nanomedicine; 2021; 16():5099. PubMed ID: 34349509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum].
    Int J Nanomedicine; 2020; 15():8873-8874. PubMed ID: 33204093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Phase-Shift, Targeted Nanoparticles for Ultrasound Molecular Imaging by Low Intensity Focused Ultrasound Irradiation [Corrigendum].
    Int J Nanomedicine; 2020; 15():6325. PubMed ID: 32943864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum].
    Int J Nanomedicine; 2022; 17():183-184. PubMed ID: 35046653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.